PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica Plc | LSE:OXB | London | Ordinary Share | GB00BDFBVT43 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 24.00 | 2.22% | 1,104.00 | 1,102.00 | 1,104.00 | 1,120.00 | 1,084.00 | 1,090.00 | 409,837 | 16:29:50 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 87.7 | -6.6 | 0.0 | - | 908 |
Oxford Biomedica (OXB) News Headlines
Oxford Biomedica News
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/4/2021 | 09:00 | ALNC |  Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal |
| 15/4/2021 | 07:00 | UKREG | Oxford Biomedica PLC Full year results |
| 06/4/2021 | 08:19 | ALNC | Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim |
| 06/4/2021 | 07:00 | UKREG | Oxford Biomedica PLC OXB signs Agreement with Boehringer Ingelheim |
| 01/4/2021 | 11:04 | UKREG | Oxford Biomedica PLC Total Voting Rights |
| 30/3/2021 | 10:22 | UKREG | Oxford Biomedica PLC Holding(s) in Company |
| 19/3/2021 | 10:29 | ALNC | Sanofi to terminate haemophilia development pact with Oxford Biomedica |
| 19/3/2021 | 08:23 | DJN | Oxford BioMedica Says Sanofi to Terminate Collaboration, License Agreement |
| 19/3/2021 | 07:01 | UKREG | Oxford Biomedica PLC Update on Sanofi Collaboration & License Agreement |
| 15/3/2021 | 10:03 | UKREG | Oxford Biomedica PLC Notice of Preliminary Results |
1 Year Oxford Biomedica Chart |
Intraday Oxford Biomedica Chart |
